
Lun Energy Raises $11.2M in Seed Funding
Lun Energy, a Copenhagen, Denmark-based startup that aims to decarbonize homes, raised $11.2m in seed funding.
Lun Energy, a Copenhagen, Denmark-based startup that aims to decarbonize homes, raised $11.2m in seed funding.
Tryp.com, an Odense, South Denmark-based flights and hotels included searching company, raised an undisclosed amount in Seed funding, at a valuation of €8.3M.
QuadSAT, an Odense, Denmark-based company focused on verification of radio frequency equipment, raised €9M in funding.
BioInnovation Institute (BII), a Copenhagen, Denmark-based international non-profit foundation incubating and accelerating world-class life science research, provided additional financial support to five companies through its Venture House program.
Teitur Trophics, an Aarhus, Denmark-based biotech company dedicated to developing treatments for patients suffering from neurodegenerative diseases, raised EUR 28M in Series A funding.
Chromologics, a Copenaghen, Denmark-based biotech company specializing in production of natural food colors, raised additional €7.1M in funding.
Logpoint, a Copenhagen, Denmark-based creator of a cybersecurity operations platform, received a majority investment from Summa Equity.
Hemab Therapeutics, a Copenhagen, Denmark and Boston, MA-based clinical-stage biotechnology company developing prophylactic therapeutics for bleeding and thrombotic disorders, raised $135M in Series B funding.
Lunar, an Aarhus, Denmark-based challenger bank, raised €35m in funding.
Reshape Biotech, a Copenhagen, Denmark-based provider of an integrated hardware and software platform digitizing microbiology experiments, raised $8.1M in funding.
Mazepay, a Copenhagen, Denmark-based fintech platform for long-tail procurement and B2B payments, raised €4M in Growth funding.
Freightify, a Singapore-based digital freight forwarders company, raised $12M in debt & equity funding.
EasyTranslate, a Copenhagen, Denmark-based marketplace of freelance translators, raised €2.75M in funding.
Tetra Pharm Technologies, a Copenhagen, Denmark-based biotech company focused on therapeutics targeting the endocannabinoid system, raised €9M in Series A funding.
Ensoma, a Boston, MA-based genomic medicines company developing one-time in vivo treatments that precisely engineer any cell of the hematopoietic system, raised $85M in Series B funding, and acquired Twelve Bio, a Copenhagen, Denmark-based CRISPR engineering company.